Pfizer to pay $67.5 million in investor lawsuit over Pristiq

NEW YORK, Nov 14: Pfizer Inc agreed to pay $67.5 million to settle a class-action lawsuit by former Wyeth Inc shareholders who said they were misled about risks associated with the antidepressant Pristiq. The all-cash settlement was disclosed on Friday, one month after Pfizer agreed to pay $164 million to settle a separate lawsuit accusing it of misleading investors about clinical trial results for the arthritis drug Celebrex. (agencies)

LEAVE A REPLY

Please enter your comment!
Please enter your name here